The efficacy of combining adjuvants with non‐surgical periodontal therapy in individuals with type 2 diabetes: A Bayesian network meta‐analysis
Journal of Clinical Periodontology · 2024
DOI: 10.1111/jcpe.13946 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Clinical Periodontology, 2024. Verfasst von Fabrício Batistin Zanatta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Postgraduate Program in Dentistry - Periodontics, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do S…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Bayes Theorem, Metronidazole, Glycated Hemoglobin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH HHS, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
This Bayesian network meta‐analysis of randomized controlled trials assessed the effect of adjuvant periodontal treatment in both periodontal and HbA1c outcomes in adult individuals with type 2 diabetes (T2DM). Materials and Methods A systematic search was done up to February 2023 comparing sub‐gingival debridement (SD) in combination with local or systemic adjuvant treatment with SD alone for individuals with T2DM. The primary outcomes were changes in absolute HbA1c levels and full‐mouth probing depth reported at 3‐ to 6‐month post‐treatment.
Results
Seventy‐two eligible publications evaluating 27 adjuvant treatments were retrieved. The combination of SD and systemic antibiotic metronidazole or SD and antioxidant alpha lipoic acid provided, respectively, 1.4% (95% credible interval [CrI] 0.48; 2.20) and 2.4% (95% CrI 1.50; 3.30) more significant improvement on HbA1c levels, and 0.89 mm (95% CrI 0.23; 1.50) and 0.92 mm (95% CrI 0.02; 0.92) greater periodontal probing depth reductions. Other adjuvant treatments provided added benefit to the periodontal outcomes without discernible effects on HbA1c.
Conclusions
Adjuvant use of metronidazole or alpha lipoic acid was the best adjunct option to provide clinically meaningful HbA1c levels and probing depth reductions. However, no strong recommendation can be drawn due to the scarcity of studies for each adjuvant treatment and the low certainty of the resultant evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Postgraduate Program in Dentistry - Periodontics, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil.
- Department of Comprehensive Oral Health - Periodontology, Adams School of Dentistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Fabrício Batistin Zanatta, Raquel Pippi Antoniazzi, Leandro Machado Oliveira, Adam D Lietzan, Patricia A Miguez, Cristiano Susin
Förderung
- NCATS NIH HHS
- NIH HHS
- National Institutes of Health
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Zanatta, F. B., Antoniazzi, R. P., Oliveira, L. M., Lietzan, A. D., Miguez, P. A., & Susin, C. (2024). The efficacy of combining adjuvants with non‐surgical periodontal therapy in individuals with type 2 diabetes: A Bayesian network meta‐analysis. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.13946
Vancouver
Zanatta FB, Antoniazzi RP, Oliveira LM, Lietzan AD, Miguez PA, Susin C. The efficacy of combining adjuvants with non‐surgical periodontal therapy in individuals with type 2 diabetes: A Bayesian network meta‐analysis. Journal of Clinical Periodontology. 2024. doi:10.1111/jcpe.13946
BibTeX
@article{Zanatta2024,
author = {Zanatta, Fabrício Batistin and Antoniazzi, Raquel Pippi and Oliveira, Leandro Machado and Lietzan, Adam D and Miguez, Patricia A and Susin, Cristiano},
title = {The efficacy of combining adjuvants with non‐surgical periodontal therapy in individuals with type 2 diabetes: A Bayesian network meta‐analysis},
journal = {Journal of Clinical Periodontology},
year = {2024},
doi = {10.1111/jcpe.13946}
}
EUVIMED